We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$536M
Cap. Flow %
9.53%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 34.82%
2 Healthcare 28.77%
3 Real Estate 5.15%
4 Financials 4.39%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EWZ icon
426
CALL
iShares MSCI Brazil ETF
EWZ
$8.99B
$233K ﹤0.01%
+500,000
New +$15.9M
CVNA icon
427
PUT
Carvana
CVNA
$79.8B
$230K ﹤0.01%
5,000,000
– –
SRPT icon
428
CALL
Sarepta Therapeutics
SRPT
$1.76B
$229K ﹤0.01%
+10,000
New +$1.13M
ALLY icon
429
PUT
Ally Financial
ALLY
$13.3B
$228K ﹤0.01%
+175,000
New +$4.89M
TDC icon
430
Teradata
TDC
$2.54B
$225K ﹤0.01%
5,000
– –
CHGG icon
431
Chegg
CHGG
$100M
$223K ﹤0.01%
25,000
– –
THO icon
432
PUT
Thor Industries
THO
$4.09B
$212K ﹤0.01%
+75,000
New +$7.83M
IOVA icon
433
CALL
Iovance Biotherapeutics
IOVA
$2.71B
$190K ﹤0.01%
+230,000
New +$1.5M
NRDY icon
434
Nerdy
NRDY
$97.8M
$185K ﹤0.01%
+50,000
New +$217K
SNDX icon
435
CALL
Syndax Pharmaceuticals
SNDX
$1.79B
$174K ﹤0.01%
+80,000
New +$1.51M
MGM icon
436
PUT
MGM Resorts International
MGM
$11.2B
$162K ﹤0.01%
35,000
– –
USB icon
437
PUT
US Bancorp
USB
$99.6B
$157K ﹤0.01%
+170,000
New +$6.19M
VLO icon
438
PUT
Valero Energy
VLO
$86.5B
$155K ﹤0.01%
+40,000
New +$5.24M
AKTS
439
DELISTED
Akoustis Technologies Inc
AKTS
$151K ﹤0.01%
200,000
– –
ADT icon
440
PUT
ADT
ADT
$5.6B
$142K ﹤0.01%
35,600
– –
EIGR
441
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$120K ﹤0.01%
13,133
– –
M icon
442
PUT
Macy's
M
$6.62B
$119K ﹤0.01%
131,000
+18,500
+16% +$259K
ACRS icon
443
CALL
Aclaris Therapeutics
ACRS
$831M
$117K ﹤0.01%
+70,000
New +$598K
VTYX
444
PUT
DELISTED
Ventyx Biosciences
VTYX
$116K ﹤0.01%
+35,000
New +$1.21M
REPL icon
445
CALL
Replimune Group
REPL
$1.03B
$115K ﹤0.01%
+40,000
New +$786K
SYBX
446
DELISTED
Synlogic
SYBX
$114K ﹤0.01%
40,548
-1
-0% -$7
VTYX
447
CALL
DELISTED
Ventyx Biosciences
VTYX
$113K ﹤0.01%
+30,000
New +$1.04M
CPRI icon
448
PUT
Capri Holdings
CPRI
$1.72B
$111K ﹤0.01%
13,900
-4,300
-24% -$195K
RARE icon
449
CALL
Ultragenyx Pharmaceutical
RARE
$2.52B
$109K ﹤0.01%
95,000
+85,000
+850% +$3.37M
NCLH icon
450
PUT
Norwegian Cruise Line
NCLH
$8.81B
$107K ﹤0.01%
55,100
– –
16 17
18
19 20

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $536M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 16% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.